JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 18, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Relapsed or Refractory B-cell Lymphoma
Interventions
BIOLOGICAL

infusion of JY231 injection

Infusion of JY231 Injection by dose of 1-10 x10\^6 TU/kg、 1-5 x10\^7 TU/kg、 5-10 x10\^7 TU/kg Administration method: intravenous infusion、intraperitoneally infusion、Lymph node infusion; Subjects will be treated with Fludarabine and Cyclophosphamide before cell infusion(PI evaluation is required).

Trial Locations (1)

510317

RECRUITING

Guangdong Second Provincial General Hospital, Guangzhou

All Listed Sponsors
lead

Guangdong Second Provincial General Hospital

OTHER